{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
BioSig Technologies, Inc.
Is BioSig Technologies, Inc. technically bullish or bearish?
As of May 16, 2025, the technical trend is bullish with strong indicators, though caution is advised due to a bearish monthly RSI, while the stock has significantly outperformed the S&P 500 over the past year.
Who are in the management team of BioSig Technologies, Inc.?
As of March 2022, the management team of BioSig Technologies, Inc. includes Kenneth Londoner (CEO and Executive Chairman), Jeffrey O'Donnell (Lead Independent Director), Anthony Zook, Andrew Filler, Donald Foley, and Patrick Gallagher (all Independent Directors). They oversee the company's strategic direction and operations.
What does BioSig Technologies, Inc. do?
BioSig Technologies, Inc. is a medical device company specializing in biomedical signal processing technology for electrophysiology and cardiac procedures. As of March 2025, it has a market cap of $180.96 million and reported a net profit loss of $3 million.
How big is BioSig Technologies, Inc.?
As of Jun 18, BioSig Technologies, Inc. has a market capitalization of 180.96 million, with recent net sales of 0.02 million and a net profit of -9.72 million. The company's shareholder's funds were -1.44 million, and total assets amounted to 0.84 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
